Genentech(DNA)
Genentech, Inc., is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotechnology company.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Actemra | Tocilizumab | 2010-01-08 | ||
| Avastin | Bevacizumab | 2004-02-26 | ||
| Cathflo activase | Alteplase | 1987-11-13 | ||
| Cotellic | Cobimetinib | 2015-11-10 | 2026-2036 | |
| Enspryng | Satralizumab | 2020-08-14 | ||
| Erivedge | Vismodegib | 2012-01-30 | 2025-2028 | |
| Esbriet | Pirfenidone | 2014-10-15 | 2026-2037 | |
| Evrysdi | Risdiplam | 2020-08-07 | 2033-2038 | |
| Gazyva | Obinutuzumab | 2013-11-01 | ||
| Hemlibra | Emicizumab | 2017-11-16 | ||
| Herceptin | Trastuzumab | 1998-09-25 | ||
| Herceptin hylecta | Hyaluronidase, Trastuzumab | 2019-02-28 | ||
| Kadcyla | Trastuzumab emtansine | 2013-02-22 | — |
1
2
3
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
12
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use